Roivant Sciences Ltd.

25
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG762791017
USD
21.18
1.08 (5.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
29.00
32.00
61.00
55.00
23.00
67.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
29.00
32.00
61.00
55.00
23.00
67.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
0.00
0.00
27.00
7.00
2.00
7.00
General and Administration Expenses
584.00
405.00
581.00
775.00
259.00
335.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,142.00
857.00
1,138.00
1,267.00
1,094.00
600.00
Operating Profit (PBDIT) excl Other Income
-1,113.00
-824.00
-1,077.00
-1,211.00
-1,070.00
-532.00
Other Income
361.00
5,514.00
77.00
518.00
109.00
101.00
Operating Profit (PBDIT)
-745.00
4,699.00
-973.00
-692.00
-961.00
-431.00
Interest
0.00
0.00
27.00
7.00
2.00
7.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
7.00
10.00
26.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-681.00
4,567.00
-1,224.00
-923.00
-898.00
-560.00
Provision for Tax
48.00
21.00
5.00
0.00
1.00
7.00
Profit After Tax
-545.00
4,664.00
-1,123.00
-845.00
-809.00
-519.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-0.24
5.23
-1.42
-1.26
-3.63
5.21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -11.19% vs -46.62% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -35.00% vs 23.45% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -111.69% vs 515.10% in Mar 2024

Compare Profit and Loss Results of Roivant Sciences Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
29.00
634.00
-605.00
-95.43%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
29.00
634.00
-605.00
-95.43%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
22.00
-22.00
-100.00%
General and Administration Expenses
584.00
218.00
366.00
167.89%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,142.00
611.00
531.00
86.91%
Operating Profit (PBDIT) excl Other Income
-1,113.00
22.00
-1,135.00
-5,159.09%
Other Income
361.00
30.00
331.00
1,103.33%
Operating Profit (PBDIT)
-745.00
139.00
-884.00
-635.97%
Interest
0.00
22.00
-22.00
-100.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
7.00
86.00
-79.00
-91.86%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-681.00
-27.00
-654.00
-2,422.22%
Provision for Tax
48.00
-1.00
49.00
4,900.00%
Profit After Tax
-545.00
-25.00
-520.00
-2,080.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-0.2371
-0.4561
0.22
48.02%
Profit And Loss - Net Sales
Net Sales 29.05 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -11.19% vs -46.62% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1,113.68 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -35.00% vs 23.45% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -545.01 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -111.69% vs 515.10% in Mar 2024